ChanningJudithPallerMD

Oncology • Washington, DC

Genitourinary Oncology, Hematologic Oncology

Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Paller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Paller's full profile

Already have an account?

Office
5255 Loughboro Road, NW
1st Floor
Washington, DC 20016
Phone+1 202-660-6500

Fax+1 202-660-6501
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005, MD

Certifications & Licensure

FL State Medical License 2021 - Present
MD State Medical License 2008 - 2025
VA State Medical License 2021 - 2024
DC State Medical License 2012 - 2024
PA State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Medical OncologyInternal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Start of enrollment: 2011 Jul 01
Completed
Phase 1, Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Trial of Mistletoe Extract in Patients With Advanced Solid Tumors Start of enrollment: 2017 Mar 01
Completed
Phase 1
Muscadine Plus (MPX) In Men With Prostate Cancer Start of enrollment: 2018 Oct 30
Terminated
Phase 3
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer Start of enrollment: 2016 May 03
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer Start of enrollment: 2022 Sep 22
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Jun Luo, Catherine H Marshall, Lukasz P Gondek, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denm...> ;The Prostate. 2024 Apr 20
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...
Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo, Andrea Harzstark, Channing J Paller, Saby George, Matthew R Zibelman, Heather ...> ;European Urology Oncology. 2024 Mar 23
Pan-Cancer Interrogation ofVariants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors.
Tukachinsky, H., Maertens, A., Decker, B., Sampson, J., Cheadle, J., Paller, C., Antonarakis, E.> ;JCO Precision Oncology. 2024 Feb 1
Therapeutic Approaches to Targeting Androgen Receptor Splice Variants.
Daniels, V., Luo, J., Kanayama, M., Paller, C.> ;Cells. 2024 Jan 4
Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board.
Gross, L., Keith, S., Russo, J., Hathaway, F., Rivera, A., Loeb, S., Cheng, H., Paller, C., Weg, E., Johnson, J., Giri, V.> ;Prostate Cancer and Prostatic Diseases. 2024 Jan 3
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Lalji, A., Mark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, Laura A Sena, Hao Wang, Hanfei Qi, Aliya Lalji, Victoria Sinibaldi, Michael A Carducci, Channing J Pall...> ;Nature Communications. 2024 Jan 2
1 citations
Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies.
van Die, M., Bone, K., Kyrø, C., Aune, D., Ee, C., Visvanathan, K., Paller, C.> ;JNCI Cancer Spectrum. 2024 Jan 4
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients.
Visvanathan, K., Petry, D., McCullough, M., May, B., Tenkasi, R., Sharma, N., Klein, C., Johnson, A., Killian, G., Camp, M., Paller, C., Couzi, R., Wilkinson, M., Jaco...> ;Journal of Cancer Survivorship. 2023 Dec 8
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
Hernandez, K., Venkat, A., Elbers, D., Bihn, J., Brophy, M., Do, N., La, J., Liu, Q., Prokhorenkov, A., Metoki-Shlubsky, N., Sung, F., Fillmore, N., Grossman, R., Pall...> ;Cold Spring Harbor Molecular Case Studies. 2023 Dec 1
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
Nicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, Amy C Mandigo, Jennifer K McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J Pal...> ;Biorxiv. 2023 Mar 23
4 citations
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Channing J Paller, Lin Wang, Wei Fu, Rajendra Kumar, Jennifer N Durham, Nilofer S Azad, Daniel A Laheru, Ilene Browner, Sushant K Kachhap, Kavya Boyapati, Thomas Odeny...> ;Cancer Research Communications. 2023 Feb 1
Analytical Validation ofGenotyping.
Marija Debeljak, Stacy Riel, Ming-Tseh Lin, James R Eshleman, Channing J Paller> ;Methods and Protocols. 2022 Dec 31
2 citations
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Pro...
Phuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y Song, Arthur Y Hung, Jason W D Hearn, Steven Miller, James A Proudfoot, Matthew P Deek, Ryan Phillips, Tamara Lotan...> ;Journal of Clinical Oncology. 2023 Feb 20
1 citations
The Society for Integrative Oncology: Two Decades of Global Leadership in Evidence-Based Integrative Health Care.
Santosh Rao, Channing J Paller, Ana Maria Lopez, Jodi MacLeod, Ting Bao, Linda E Carlson> ;Journal of Integrative and Complementary Medicine. 2022 Sep 1
58 citations
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOL...
Matthew P Deek, Kim Van der Eecken, Philip Sutera, Rebecca A Deek, Valérie Fonteyne, Adrianna A Mendes, Karel Decaestecker, Ana Ponce Kiess, Nicolaas Lumen, Ryan Phill...> ;Journal of Clinical Oncology. 2022 Oct 10
4 citations
Cost-Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-Analysis.
Lin Wang, Hwanhee Hong, G Caleb Alexander, Otis W Brawley, Channing J Paller, Jeromie Ballreich> ;Value in Health. 2022 May 1
15 citations
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain, Shilpa Gupta, Melissa Plets, Primo N Lara, Andrea L Harzstark, Przemyslaw W Twardowski, Channing J Paller, Dylan ...> ;Journal of Clinical Oncology. 2022 Oct 1
9 citations
Best Approaches and Updates for Prostate Cancer Biochemical Recurrence.
Nicholas I Simon, Chris Parker, Thomas A Hope, Channing J Paller> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
14 citations
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, Anis Hamid, Emily Grist, Gerhardt Attard, Tamara Lotan, Adrianna A Mendes, Channing J Paller, Michael A Carducci, Ash...> ;Prostate Cancer and Prostatic Diseases. 2022 Apr 1
Applications for open access normalized synthesis in metastatic prostate cancer trials.
Thomas Luechtefeld, Thomas Bozada Jr, Rahul Goel, Lin Wang, Channing J Paller> ;Frontiers in Artificial Intelligence. 2022 Jan 1
3 citations
Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Re...
Dame Idossa, Terence Friedlander, Channing J Paller, Charles J Ryan, Hala T Borno> ;Frontiers in Oncology. 2022 Jan 1
3 citations
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer.
Ana Filipa Palma Dos Reis, Diana Simão, Thomas Odeny, Chiara Rodrigues, Mário Fontes-Sousa, Ricardo da Luz, Rajasree Pia Chowdry, Sarah J Welsh, Channing Paller, Pedro...> ;Kidney Cancer. 2022 Jan 1
Editorial: Big Data and machine learning in cancer theranostics.
Fabricio Alves Barbosa da Silva, Jack Adam Tuszynski, Helder Nakaya, Channing J Paller> ;Frontiers in Big Data. 2022 Jan 1
3 citations
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prosta...
Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath,...> ;European Urology Open Science. 2021 Dec 1
Join now to see all

Journal Articles

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
Channing J Paller, Otis Brawley, JAMA Oncology
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
Emmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology
TGF‐Β Receptor I Inhibitor Enhances Response to Enzalutamide in a Pre‐Clinical Model of Advanced Prostate Cancer
Channing Paller, Cameron A Wade, The Prostate

Lectures

FACTS: Factors affecting combination trial success.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Johns Hopkins Study Highlights Promise of IV Mistletoe Extract for Cancer Therapy – Twin CitiesMarch 24th, 2023
Johns Hopkins Study Highlights Promise of IV Mistletoe Extract for Cancer Therapy – the Mercury NewsMarch 24th, 2023
Johns Hopkins Study Highlights Promise of IV Mistletoe Extract for Cancer TherapyMarch 21st, 2023
Join now to see all